140 cholecystectomised patients were subjected to out-patient clinical follow-up (follow-up range 15.5 ± 7.1 months) as were 45 patients who had various operations on the digestive tract. The controlled study was divided into two phases: epidemiology and therapy. The results of the epidemiological trial clearly showed that in about half the cases treated cholecystectomy leaves certain problems of digestive dysfunction (dyspeptic-pain syndrome) unresolved but does not cause new symptoms. Hence there is no justification for the term 'post-cholecystectomy syndrome'. A double blind therapeutic trial confirmed the efficacy of UDCA in the treatment of dyspepsia in cholecystectomised patients (p = 0,03) but showed that it has little influence on the pain factor (p = 1,00).
|Translated title of the contribution||Does postcholecystectomy syndrome exist? Epidemiological findings and the therapeutic effects of UDCA|
|Number of pages||8|
|Publication status||Published - 1986|
ASJC Scopus subject areas